Health and Healthcare
606 Articles
ThinkstockBiotech stocks took it on the chin during the sell-off. In fact, biotech stocks may have even led the sell-off…
In a new report, the Credit Suisse team says large cap biotech is cheaper than the S&P 500 on 2016…
ThinkstockWhen the biotech sell-off started in late February, the stocks had been market leaders for almost four years. The staggering…
Jon OggMost investors buying Big Pharma stocks these days are buying them for dividends and somewhat of a defensive position…
In a new report from RBC, its analysts say that biotech stocks trading at some of the lowest forward multiples…
Teva Pharmaceutical shares reached a new multiyear high Monday after the U.S. Supreme Court agreed to hear its appeal to…
courtesy of Morgan StanleyLike many of its Wall Street peers, the brutal sell-off in the biotechnology space has Morgan Stanley…
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Thursday, March 27, 2014.…
For the second time in less than a month, the biotechnology sector got whacked when once again, chatter coming from…
Many bears on Wall Street say that biotech stocks are overvalued, but many trade in line with historical valuations. In…
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms in Thursday, March 6, 2014.…
Merrill Lynch likes the health care sector and has made no secret that they think that it can continue to…
After largely shying away in the previous period, short sellers returned to many of the leading biotech and emerging pharmaceutical…
Biogen Idec has announced that Chairman William D. Young will retire from the its board of directors and will be…
The equity team at Jefferies has pulled their best ideas for clients to review while the market is mired in…
Our top personal finance-related articles today. Your wallet will thank you later.